Equities analysts predict that Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Rating) will report $14.40 million in sales for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Foghorn Therapeutics’ earnings, with estimates ranging from $10.00 million to $18.80 million. Foghorn Therapeutics reported sales of $290,000.00 in the same quarter last year, which […]